GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Anebulo Pharmaceuticals
Shares of Anebulo, a biopharmaceutical company developing an antidote for cannabis overdose, are a highly speculative bet. Their price is driven not by financial performance, but by news from the lab and potential demand for such a niche product.
Share prices of companies in the market segment - Narco farm
Anebulo Pharmaceuticals is a biopharmaceutical company developing a drug for the rapid relief of symptoms of acute cannabis intoxication. We classify it as a "Drug Farm" in the context of therapeutics. The chart below shows the dynamics of this highly specialized segment.
Broad Market Index - GURU.Markets
Anebulo Pharmaceuticals is a biotech company developing medications to treat the effects of psychoactive substance overdose, particularly cannabis. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Anebulo's performance.
Change in the price of a company, segment, and market as a whole per day
ANEB - Daily change in the company's share price Anebulo Pharmaceuticals
For Anebulo Pharmaceuticals, a company developing addiction medications, daily price change is a measure of extreme volatility. It reflects the market's reaction to research data and regulatory risks, and is a critical parameter for risk assessment formulas on the System.GURU.Markets platform.
Daily change in the price of a set of shares in a market segment - Narco farm
Anebulo Pharmaceuticals, Inc. is a biotech company. This chart shows the sector's extreme volatility. Comparison with ANEB, which focuses on addiction treatment, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Anebulo Pharmaceuticals develops medications to treat the effects of psychoactive substance overdose. Given the severity of the social problem, its developments are attracting attention. The company's shares are volatile and dependent on research progress, contributing to market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Anebulo Pharmaceuticals
Anebulo Pharmaceuticals' year-end performance is a story about the development of a drug to treat cannabis overdose. Its market capitalization over the next 12 months depends entirely on progress in clinical trials. Successful development of such an "antidote" could open up a significant market niche for the company amid growing cannabis legalization.
Annual dynamics of market capitalization of the market segment - Narco farm
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotech company developing drugs for the treatment of psychoactive substance poisoning. Its stock performance is entirely dependent on clinical trial results. The chart reflects the high risks and potential for breakthroughs in this niche market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Anebulo is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of its drug trials. The company's chart exists in a world of its own, where the key events are data releases, not macroeconomic statistics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is developing a drug to treat the effects of cannabinoid overdose. Its monthly performance is entirely dependent on the success of its clinical trials. As a single-product company, any news about its development triggers a strong investor reaction, as reflected in the chart.
Monthly dynamics of market capitalization of the market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing drugs to treat the effects of acute intoxication with cannabinoids and other psychoactive substances. The chart below shows the overall dynamics of the biotech sector, where the company occupies a narrow and socially significant niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Anebulo Pharmaceuticals is a biotech company developing drugs to treat the effects of psychoactive drug overdose. Its shares are a venture bet on the success of one or two drugs. Their performance depends entirely on news from the lab and regulators, not on the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Anebulo Pharmaceuticals
The weekly performance of Anebulo, a biopharmaceutical company developing an antidote for cannabis overdose, reflects the downside of legalization. Its stock price is responding to clinical trial data and the growing need for emergency medicine solutions.
Weekly dynamics of market capitalization of the market segment - Narco farm
Anebulo Pharmaceuticals develops medications to reverse the effects of psychoactive substance overdose. This is a highly specialized and socially significant niche in the pharmaceutical industry. The chart will show whether Anebulo's share price performance is related to its own clinical trials or reflects broader industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Anebulo Pharmaceuticals is a biopharmaceutical company. Its success depends on the results of clinical trials. This chart will help you understand: does Anebulo live in its own world of scientific news, or are the overall market conditions and risk appetite in the biotech sector actually influencing its stock price?
Market capitalization of the company, segment and market as a whole
ANEB - Market capitalization of the company Anebulo Pharmaceuticals
Anebulo's market capitalization chart tells the story of a biotech company developing a drug to treat the effects of cannabinoid and other psychoactive substance overdoses. Its volatile dynamics reflect investors' assessments of the potential to solve this growing medical problem. Its trajectory reflects progress in clinical trials.
ANEB - Share of the company's market capitalization Anebulo Pharmaceuticals within the market segment - Narco farm
Anebulo Pharmaceuticals is a biopharmaceutical company developing drugs to treat the effects of acute intoxication with cannabinoids and other psychoactive substances. Its market capitalization reflects its niche specialization. The chart below shows how the market perceives the potential of its unique development pipeline.
Market capitalization of the market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabis overdose. The chart below shows the market capitalization of this niche sector. Its dynamics reflect both the growing prevalence of cannabis and the need for treatments to combat its adverse effects.
Market capitalization of all companies included in a broad market index - GURU.Markets
Anebulo Pharmaceuticals develops medications to treat the effects of psychoactive drug overdoses. Its market capitalization reflects a pressing social problem and the need for new medical solutions. Its performance on the overall chart is a financial indicator of how medicine is addressing public health crises.
Book value capitalization of the company, segment and market as a whole
ANEB - Book value capitalization of the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals' foundation is its capital, which is invested in developing a drug for the emergency treatment of cannabinoid overdose. This is a real, scientific foundation for solving a specific but growing medical problem. How has this unique biotech asset evolved? The chart below shows its dynamics.
ANEB - Share of the company's book capitalization Anebulo Pharmaceuticals within the market segment - Narco farm
Anebulo Pharmaceuticals is developing a drug to treat the effects of cannabinoid overdose, which requires R&D laboratories. The chart shows the share of these research-intensive assets, reflecting the physical foundation of its work in this highly specialized field.
Market segment balance sheet capitalization - Narco farm
Anebulo Pharmaceuticals develops medications to treat the effects of psychoactive substance overdose. It's a highly specialized, science-intensive business. A balance sheet capitalization chart will show how "light" the company's capital base is.
Book value of all companies included in the broad market index - GURU.Markets
Anebulo Pharmaceuticals develops drugs to treat the effects of acute intoxication. Its book value represents its clinical trial capital and development pipeline. The chart shows the material foundation on which it is building its search for a solution to this pressing medical problem.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Anebulo Pharmaceuticals
Anebulo's balance sheet is capital. But investors see it as the creator of an "antidote to overdose." The chart shows the "hope factor": the premium the market is paying for its drug's potential to solve a pressing medical problem.
Market to book capitalization ratio in a market segment - Narco farm
Anebulo Pharmaceuticals develops drugs to treat the effects of psychoactive drug overdose. Its valuation is based on the potential of its lead drug. The chart shows how much investors believe in the need for this treatment and the success of its clinical trials.
Market to book capitalization ratio for the market as a whole
Anebulo Pharmaceuticals is developing a drug to quickly reverse the effects of cannabis overdose. It's a niche but potentially important product in the era of marijuana legalization. This chart shows the overall market valuation, but how do investors value the company creating an "antidote" for one of the most widely used psychoactive substances?
Debts of the company, segment and market as a whole
ANEB - Company debts Anebulo Pharmaceuticals
Anebulo, a pharmaceutical company, develops medications for emergency situations, such as overdose treatment. This is a highly specialized area. This chart shows how the company is raising capital to finance clinical trials of its candidates, targeting the emergency medical care market.
Market segment debts - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a drug to treat the effects of cannabinoid overdose. This is a very niche market. This chart shows how the company is funding its clinical trials to address this specific medical problem.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Anebulo Pharmaceuticals
Anebulo Pharmaceuticals develops drugs to treat the effects of psychoactive drug overdose. This chart shows how the company finances its research in a socially significant yet regulatoryly challenging niche. The company's debt burden reflects the financial risks involved in developing a potentially life-saving treatment.
Market segment debt to market segment book capitalization - Narco farm
Anebulo Pharmaceuticals develops drugs to treat the effects of acute cannabinoid and psychedelic intoxication. This chart shows the debt burden in the niche pharmaceutical sector. It helps understand how companies finance their unique clinical trials and how Anebulo's financial model compares to this.
Debt to book value of all companies in the market
Anebulo Pharmaceuticals develops drugs to treat the effects of psychoactive drug overdose. It is a highly specialized pharmaceutical company in the research stage. Its financial model is based on equity capital. The graph of the market's total debt burden only emphasizes that its risks lie in the scientific, not financial, realm.
P/E of the company, segment and market as a whole
P/E - Anebulo Pharmaceuticals
This chart for Anebulo Pharmaceuticals, a company developing cannabinoid-based overdose treatments, shows the valuation of its unique niche. The multiple reflects investors' belief in the growing need for such a treatment as cannabis legalization and widespread adoption creates a new and potentially large market.
P/E of the market segment - Narco farm
Antidote development, which Anebulo is pursuing, is a niche pharmaceutical. This chart shows the average valuation for biopharmaceutical companies. It helps to understand that Anebulo, with its cannabis overdose treatment, is valued based on the potential demand for such a product under legalization.
P/E of the market as a whole
Anebulo Pharmaceuticals is a biotech company developing drugs to treat the effects of acute intoxication with cannabinoids and other psychoactive substances. This is a niche and socially significant field. This chart, reflecting biotech sentiment, helps understand how the market views the commercial potential of these specialized therapeutics.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabinoid overdose. This chart reflects speculative expectations for its niche product. The trend reflects the market's assessment of the need for this treatment and the likelihood of success in clinical trials.
%20P%2FE%20Anebulo%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Anebulo-Pharmaceuticals&v=1772513780434 "Chart of the company's future (projected) P/E Anebulo Pharmaceuticals")
Future (projected) P/E of the market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a drug to reverse the effects of cannabinoid overdose. This chart shows profitability expectations for the pharmaceutical sector, providing insight into how investors assess the potential demand for such a niche yet important product in the era of cannabis legalization.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772513780451 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Anebulo Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat the effects of acute cannabinoid intoxication. This chart shows investors' risk appetite. For a company operating in a narrow and specific niche, it reflects the market's willingness to fund developments to address new medical problems.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513780463 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabinoid overdose. Its financial results, as shown in this chart, are derived from clinical trial expenses. It illustrates its efforts to develop a solution to a specific, increasingly pressing medical problem.
Profit of companies in the market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a treatment for the effects of acute cannabinoid overdose. This is a niche but important medical need. This graph illustrates how pharmaceutical companies are finding new markets and profit potential by addressing specific problems arising from social or cultural changes.
Overall market profit
Anebulo Pharmaceuticals is a biotech company developing a drug to reverse the effects of cannabis overdose. It's a very niche product, but potentially important as marijuana becomes legalized. The company's success depends on clinical trials and the recognition of a need for such a treatment. This is an example of how new social trends are creating new markets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biopharmaceutical company developing drugs to treat the effects of acute cannabinoid intoxication. The profit/loss forecast in this chart reflects analysts' expectations for clinical trials in this unique niche.
%20profit%20of%20the%20company%20Anebulo%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Anebulo-Pharmaceuticals&v=1772513780498 "Graph of future (projected) profit of the company Anebulo Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Narco farm
Anebulo Pharmaceuticals is a biopharmaceutical company developing a treatment for acute cannabis intoxication. This is a niche but potentially in-demand area. This chart shows the revenue forecast for the narcotics pharmaceuticals sector, allowing one to assess the market's perception of the potential of Anebulo's unique product in the face of cannabis legalization.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772513780501 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Anebulo Pharmaceuticals is a biotech company developing drugs to treat the effects of psychoactive drug overdose. Its success depends on clinical trials. This schedule, reflecting market sentiment, affects the availability of funding for such highly specialized medical research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513780516 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is developing a drug to quickly reverse the effects of cannabis overdose. This chart shows how investors assess the potential market for this unique product. This assessment is a bet on clinical success and the need for an "antidote" amid marijuana legalization.
P/S market segment - Narco farm
Anebulo Pharmaceuticals is a biopharmaceutical company developing treatments for the effects of acute cannabinoid intoxication. This chart shows the industry average price-to-sales ratio. It reflects investor expectations for the company's potential to address a problem that has become increasingly pressing with the legalization of cannabis.
P/S of the market as a whole
Anebulo Pharmaceuticals is a clinical-stage biopharmaceutical company developing a treatment for acute cannabinoid intoxication. This is a niche but important medical need. This overall market valuation chart helps understand how investors value companies working on specific healthcare challenges.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biopharmaceutical company developing a drug to reverse the effects of cannabinoid overdose. This chart shows its valuation relative to future projected sales. It reflects investor expectations regarding the need for this drug and the success of its clinical trials.
%20P%2FS%20Anebulo%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Anebulo-Pharmaceuticals&v=1772513780537 "The graph of the company's future (projected) P/S Anebulo Pharmaceuticals")
Future (projected) P/S of the market segment - Narco farm
Anebulo Pharmaceuticals is a biopharmaceutical company developing drugs to treat the effects of acute cannabinoid intoxication and other CNS disorders. This chart reflects investor expectations for its niche but important clinical program and its potential future revenue.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772513780542 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabinoid overdose. Its success depends on the results of clinical trials. This general expectations schedule for ANEB is not a direct driver. Demand for its product will be determined by medical needs, not the state of the economy.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513780546 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Anebulo Pharmaceuticals
This chart illustrates the financial path of a biotech company. For Anebulo Pharmaceuticals, focused on developing a drug to treat the effects of cannabinoid overdose, it reflects the funding needed to conduct clinical trials.
Sales of companies in the market segment - Narco farm
Anebulo Pharmaceuticals is a clinical-stage biopharmaceutical company developing a treatment for acute cannabis intoxication. Growing legalization is creating a demand for such a product. This chart shows revenue in the pharmaceutical sector. Anebulo's success could create an entirely new niche market addressing the side effects of cannabis.
Overall market sales
Anebulo Pharmaceuticals is a biotech company developing a drug to reverse the effects of cannabinoid overdose. As cannabis becomes legalized, the need for such solutions is growing. The company operates in a new, emerging market driven by broader social and legislative changes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is developing a drug to quickly reverse the effects of cannabinoid overdose. Future sales projections depend on the success of clinical trials and potential demand for this "antidote."
%20sales%20of%20the%20company%20Anebulo%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Anebulo-Pharmaceuticals&v=1772513780661 "Schedule of future (projected) sales of the company Anebulo Pharmaceuticals")
Future (projected) sales of companies in the market segment - Narco farm
Anebulo Pharmaceuticals develops medications to treat the effects of psychoactive substance overdose. The forecast for this pharmaceutical niche shows a growing need. The graph reflects how social problems such as drug addiction create a pressing need for effective and fast-acting antidotes.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772513780679 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Anebulo Pharmaceuticals is a biotechnology company developing drugs to treat the effects of acute cannabinoid intoxication. Its success depends on clinical trials and the recognition of the need for such treatment. This general economic activity schedule does not affect its operations, but may impact the availability of funding for research.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513780699 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biopharmaceutical company developing a drug to reverse the effects of cannabinoid overdose. Currently in clinical trials, the company is incurring significant R&D expenditures. This chart shows the company's investment in addressing this specific and pressing medical need.
Market segment marginality - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a drug to reverse the effects of cannabinoid overdose. Profitability will depend on the success of clinical trials and demand for such a specific product. This chart reflects the company's operational structure in this unique pharmaceutical niche.
Market marginality as a whole
Anebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a treatment for cannabinoid overdose. This chart shows the overall profit margin. Compared to this, Anebulo is a niche biotech. Its future profitability depends on clinical success and the significant demand for such a specific drug.
Employees in the company, segment and market as a whole
Number of employees in the company Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabinoid overdose. Its extremely small staff consists of a core management and scientific team. Any increase in this graph would indicate significant progress in clinical trials and a move closer to potential market launch.
Share of the company's employees Anebulo Pharmaceuticals within the market segment - Narco farm
Anebulo Pharmaceuticals is a clinical-stage biopharmaceutical company developing a treatment for the effects of acute cannabinoid intoxication. This chart highlights its unique and narrow niche. It reflects the percentage of pharmacologists and clinical research specialists working on this specific problem that Anebulo attracts.
Number of employees in the market segment - Narco farm
Anebulo Pharmaceuticals is developing a drug to quickly reverse the effects of cannabis overdose. This chart illustrates its work in a highly specialized pharmaceutical niche. The company's growth is driven by addressing a problem that is becoming increasingly pressing with the legalization of cannabis, creating a new market for emergency medications.
Number of employees in the market as a whole
Anebulo Pharmaceuticals is a biotech company developing medications to treat the effects of psychoactive substance overdose. Their work focuses on medicine and addressing pressing social issues. This general work schedule is irrelevant to them. Their success depends on clinical data and the healthcare system's need for such a drug.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals is a biotech company developing a drug to rapidly reverse the effects of cannabis overdose. It's a highly specialized but important niche. This chart shows how the market values this solution to a specific medical problem. The high market capitalization per employee reflects the uniqueness of their development and potential demand.
%20of%20the%20company%20Anebulo%20Pharmaceuticals%20(ANEB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Anebulo-Pharmaceuticals-ANEB&v=1772513780788 "Chart of market capitalization per employee (in thousands of dollars) of the company Anebulo Pharmaceuticals (ANEB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Anebulo Pharmaceuticals develops drugs to treat the effects of psychoactive substance overdose. This is a narrow and socially significant niche in the pharmaceutical industry. This chart shows how the market perceives the potential of its developments. The high cost per employee reflects the high expectations for clinical trials conducted by a small team.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772513780790 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Anebulo Pharmaceuticals develops drugs to treat the effects of psychoactive drug overdose. This chart reflects the employee's high praise, as the company is working to address a pressing medical need, and a successful drug could have a significant market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513780792 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals is a biotech company developing a treatment for cannabinoid overdose (acute psychosis). This is niche R&D. This metric is likely negative. It reflects how much the company is investing in each employee to develop and test this antidote, the demand for which may increase with legalization.
%20Chart%20Anebulo%20Pharmaceuticals%20(ANEB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Anebulo-Pharmaceuticals-ANEB&v=1772513780793 "Company Profit Per Employee (in thousands of dollars) Chart Anebulo Pharmaceuticals (ANEB)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Anebulo Pharmaceuticals (ANEB) is a biotech company developing drugs to treat addiction and overdose. As with many biotech companies, this graph is a guide to the future. Currently, profitability is negative. ANEB's success will depend on whether its team can prove the efficacy of its drugs in this complex but socially significant area.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772513780797 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Anebulo Pharmaceuticals (ANEB) is a biotech company developing drugs to treat the effects of overdose (for example, cannabis). This is a very niche R&D area, and negative profit per employee is the norm. The graph shows the "cost" of the team of scientists working on this specific antidote.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513780820 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals develops medications to treat the effects of psychoactive drug overdose. This chart reflects its status as an R&D company. Lack of revenue is normal. In the future, this metric will become a measure of the commercial success of its drugs, which address an important and unmet medical need.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Anebulo-Pharmaceuticals-ANEB&v=1772513780837 "Sales chart per company employee Anebulo Pharmaceuticals (ANEB)")
Sales per employee in the market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing treatments for acute cannabinoid overdose. This is a very narrow niche. At the R&D stage, this metric reflects how effectively their research team generates revenue (e.g., from partnerships) per employee.
Sales per employee for the market as a whole
Anebulo Pharmaceuticals is a biotech company developing a treatment for acute cannabinoid overdose. It's a niche R&D company. This chart shows revenue per employee. For a clinical-stage company, this figure is expected to be zero or very low (from grants), as its entire research staff is focused on drug development.
Short shares by company, segment and market as a whole
Shares shorted by company Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals is a biotech company developing a drug to treat the effects of overdose (for example, with cannabinoids or other substances). This chart shows bearish bets. Bears may doubt the market size for such a drug or the success of its clinical trials.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Anebulo-Pharmaceuticals-ANEB&v=1772513780898 "Short Shares Chart for the Company Anebulo Pharmaceuticals (ANEB)")
Shares shorted by market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing drugs to treat the effects of overdose (for example, cannabinoids). This chart shows overall short positions in the biotech sector. A high chart reflects general market skepticism about the sector, possibly due to fears of research failures.
Shares shorted by the overall market
Anebulo (ANEB) is a clinical-stage biotech company. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs, fearing ANEB will be unable to raise capital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Anebulo Pharmaceuticals (ANEB)
Anebulo is a biotech company operating in a unique niche: they're developing an "antidote" for cannabis (marijuana) overdoses. This is a highly speculative R&D bet. This chart measures the level of hope. It shows when the stock is "overbought" on anticipation of R&D news or "oversold" due to delays.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Anebulo-Pharmaceuticals-ANEB&v=1772513780922 "RSI 14 indicator chart for the company's stock Anebulo Pharmaceuticals (ANEB)")
RSI 14 Market Segment - Narco farm
Anebulo (ANEB) is an "antidote" for cannabis. It's a biotech whose *sole* bet is a drug (ANEB-001) for *quickly* reversing cannabis "overdoses." The "Narco farm" (cannabis) sector is the "king" of "hype." RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is ANEB's growth a niche product or a part of the *general* "hype"?
RSI 14 for the overall market
Anebulo Pharmaceuticals (ANEB) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ANEB (Anebulo Pharmaceuticals)
Anebulo Pharmaceuticals is a biotech company developing a drug (ANEB-001) for the treatment of acute cannabinoid poisoning (overdose). This chart shows the average target price. Analysts' forecasts are based on clinical data and the potential market size for this antidote.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ANEB-Anebulo-Pharmaceuticals&v=1772513780995 "A chart showing analyst consensus forecasts for the expected stock price. ANEB (Anebulo Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price ANEB (Anebulo Pharmaceuticals)
Anebulo is a biopharmaceutical company developing an antidote (ANEB-001) for the rapid relief of acute cannabis overdose symptoms. This chart measures the gap between the current price and the consensus target price. It shows the potential analysts see in this niche but important drug.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ANEB-Anebulo-Pharmaceuticals&v=1772513781011 "A chart showing the difference between the consensus forecast and the actual stock price. ANEB (Anebulo Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Anebulo Pharmaceuticals is a biotech company developing an antidote for cannabis overdose, as well as drugs for addiction treatment. This chart reflects general expectations for the drug farm (and pharmaceutical) sector. It shows whether experts believe there will be demand for treatments for the side effects of legalization.
Analysts' consensus forecast for the overall market share price
Anebulo Pharmaceuticals (ANEB) is a biopharmaceutical company developing a cannabis "antidote." Their drug is designed to quickly relieve the symptoms of marijuana overdose. It's a niche market. This chart shows the overall risk appetite, reflecting the willingness of investors to invest in speculative R&D projects in niche areas.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is the antidote for party animals. It's a biotech company whose flagship (and only) bet is ANEB-001, a drug designed to quickly reverse the effects of cannabis (THC) overdose. This chart is a pure indicator of their R&D. Its dynamics are all or nothing, depending entirely on their clinical data and their chances of FDA approval.
AKIMA Market Segment Index - Narco farm
Anebulo Pharmaceuticals is a biotech company developing a drug (ANEB-001) for the treatment of acute cannabinoid poisoning (overdose). This chart shows the average pharmaceutical sector index. It helps investors assess how Anebulo's niche approach compares to the average pharmaceutical company.
The AKIM Index for the overall market
Anebulo Pharmaceuticals is a biotech company developing an antidote for acute cannabinoid intoxication, addressing the problem of overdose in the era of legalization. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this niche emergency medicine company stacks up against overall economic trends.
